Literature DB >> 16012920

[Effect of botulinum toxin a and B on vegetative cardiac innervation].

M Meichsner1, G Reichel.   

Abstract

The objective of this study was to examine whether vegetative cardiac innervation is affected by local application of botulinum toxin A and B. For that purpose, heart rate variability (HRV) was measured in 29 patients treated with botulinum toxin A and 26 patients treated with botulinum toxin B both prior to and three weeks following injection. Among the 14 parameters studied, 9 and 10 had significantly changed in terms of decreased HRV following treatment with botulinum toxin A and B, respectively. Obviously, either type of botulinum toxin exerts a systemic effect, although a clear-cut difference between the two preparations was undetectable. By and large, the changes observed tend to be low compared to, for instance, cardiac effects known to occur with tricyclic agents. However, the results might be of relevance for the use of botulinum toxins in patients with a history of cardiac disease since a reduction in HRV correlates with an increased incidence of cardiovascular events. Therefore, an ECG study is advised prior to onset of therapy with botulinum toxin. In addition, nonjudicious use of botulinum toxin outside a defined range of medical indications should be reassessed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012920     DOI: 10.1055/s-2004-830272

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  3 in total

1.  Impaired heart rate variability in cervical dystonia is associated to depression.

Authors:  F Hentschel; D Dressler; M Abele; S Paus
Journal:  J Neural Transm (Vienna)       Date:  2016-11-05       Impact factor: 3.575

2.  Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A.

Authors:  D Tiple; S Strano; C Colosimo; G Fabbrini; G Calcagnini; M Prencipe; A Berardelli
Journal:  J Neurol       Date:  2008-05-07       Impact factor: 4.849

Review 3.  Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment.

Authors:  Alessio Baricich; Alessandro Picelli; Andrea Santamato; Stefano Carda; Alessandro de Sire; Nicola Smania; Carlo Cisari; Marco Invernizzi
Journal:  Clin Drug Investig       Date:  2018-11       Impact factor: 2.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.